Targeted therapy in sarcomas: mammalian target of rapamycin inhibitors from bench to bedside
Author:
Affiliation:
1. University Campus Bio-Medico, Medical Oncology, via Alvaro del Portillo, 200, Rome, Italy
2. University Campus Biomedico, Via Emilio Longoni 69, 155, Rome, Italy
Publisher
Informa Healthcare
Subject
Pharmacology (medical),Pharmacology,General Medicine
Link
https://www.tandfonline.com/doi/pdf/10.1517/13543784.2011.628984
Reference173 articles.
1. Targeting Sarcomas: Novel Biological Agents and Future Perspectives
2. The Biology Behind mTOR Inhibition in Sarcoma
3. Advances in sarcoma genomics and new therapeutic targets
4. miRNA Profiling: How to Bypass the Current Difficulties in the Diagnosis and Treatment of Sarcomas
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Sirolimus Pharmacokinetics Variability Points to the Relevance of Therapeutic Drug Monitoring in Pediatric Oncology;Pharmaceutics;2021-03-30
2. Safety and accuracy of core biopsy in retroperitoneal sarcomas;Asia-Pacific Journal of Clinical Oncology;2013-10-31
3. Efficacy and Safety of Endostar®Combined with Chemotherapy in Patients with Advanced Soft Tissue Sarcomas;Asian Pacific Journal of Cancer Prevention;2013-07-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3